Fund PR – Sound Bioventures

All Events Fund articles Fund PR Portfolio articles Portfolio PR

Sound Bioventures 2024 Year in Review

2025.01.212025.01.22 / Backed by our investors and partners, Sound Bioventures has in 2024 continued to grow our impactful trans-Atlantic portfolio of life-changing biotech companies. Guided by a commitment to advance heal ...

Sound Bioventures appoints Fredrik Lehmann as its first Entrepreneur-in-Residence

2023.10.132023.12.20 / Stockholm, Sweden and Cambridge, MA, USA – 13 October 2023 - Sound Bioventures, a venture capital fund investing in about-to-be clinical or clinical stage private companies in Europe and the USA deve ...

Philip Brainin, Analyst - Sound Bioventures

New members to the team

2022.12.152023.12.20 / Philip Brainin, Analyst, MD, PhD, MBA Today it was announced that Philip Brainin has joined the Sound Bioventures team. Before joining Sound Bioventures in December 2022, Philip worked as an in ...

Brey Therapeutics

Novo Holdings and Sound Bioventures launch Breye Therapeutics to develop novel oral therapies for ophthalmologic diseases

2022.11.102024.05.13 / Industry expert Ulrik Mouritzen M.D. appointed Chief Executive OfficerFunding to advance lead asset to phase 1b clinical trial and further build pipeline Copenhagen, Denmark, 10 November 2022 – Br ...

Johan Kördel - Sound Bioventures

Johan Kördel is interviewed about Sound Bioventures and its Investment Strategy by BioStock

2022.11.042023.12.20 / To be able to contribute to the development of new drugs is very exciting! I am passionate about helping people to a better life - says Johan Kördel Sound Bioventures strategy is to invest in priv ...

Johan Kördel appears on DI TV stating that “the time to invest in Biotech is now”!

2022.10.052023.12.20 / Sound Bioventures is a venture capital fund that invests in private clinical stage therapeutics companies. The managing partner Johan Kördel was invited to the Swedish financial media channel Dagens ...

Thomas Tan joins Sound Bioventures

2022.04.012023.12.20 / Today it was announced that Thomas Tan has joined the Sound Bioventures team as a Principal. Thomas will identify new investment opportunities, conduct scientific and commercial due diligence, and pa ...

Read about Ester Sklarsky and how her curiosity for life-science and innovation shaped a career in VC, permitting her to pursue the therapeutics of tomorrow and make a difference for patients.

Ester Sklarsky joins Sound Bioventures

2022.02.072023.12.20 / Today we welcome Ester Sklarsky to the Sound Bioventures investment team as an Associate. Ester will manage our dealflow, identify new investment opportunities and conduct scientific and commercial d ...

Broad Media Coverage of the launch of Sound Bioventures Fund I

2022.01.142023.12.20 / The launch of Sound Bioventures Fund I resulted in broad coverage of the international life science trade media and Scandinavian financial press. Our strategy to invest in clinical, or near clinical, ...

Sound Bioventures raises € 110 million for new biotherapeutics venture fund

2022.01.042024.09.11 / January 4th, 2022, Malmö, Sweden and Copenhagen, Denmark: Sound Bioventures, a Scandinavia-based lifesciences venture capital firm, announced the first close of its first fund at €110 millio ...

Sound Bioventures Works with Andulf Advokater

2021.12.152023.12.20 / After a number of positive referals, Sound Bioventures decided to hire Andulf Advokater with Anders Apell and Ulf Edebrink, as their legal representatives. Anders and Ulf where part of founding Andul ...